Helvetica Chimica Acta · 2003 · 21 citations · 18 references
PharmacyMedicinal ChemistryPharmacologyOrganometallic ChemistryStructure-activity RelationshipsSynthetic Medicinal ChemistryNatural Product Drug DiscoveryRetrosynthetic AnalysisAlkaloid Skeleton FormationAlkylation CatalysisAlkylation ProcessesAlkylation ReactionsChemical Synthesis Of AnaloguesMedicinal Chemistry ApplicationsMedicinal HeterocyclesRing Structure
Abstract (±)‐Desoxynoreseroline ( 3 ), the basic ring structure of the pharmacologically active alkaloid physostigmine ( 1 ), was synthesized starting from 3‐allyl‐1,3‐dimethyloxindole ( 9 ). The latter was prepared from the corresponding 2 H ‐azirin‐3‐amine 6 by a BF 3 ‐catalyzed ring enlargement via an amidinium intermediate 7 ( Scheme 1 ). An alternative synthesis of 9 was also carried out by the reaction of N ‐methylaniline with 2‐bromopropanoyl bromide ( 12 ), followed by intramolecular Friedel–Crafts alkylation of the formed anilide 13 to give Julian 's oxindole 11 . Further alkylation of 11 with allyl bromide in the presence of LDA gave 9 in an excellent yield ( Scheme 3 ). Ozonolysis of 9 , followed by mild reduction with (EtO) 3 P, gave the aldehyde 14 , whose structure was chemically established by the transformation to the corresponding acetal 15 ( Scheme 4 ). Condensation of 14 with hydroxylamine and hydrazine derivatives, respectively, gave the corresponding imine derivatives 16a – 16d as a mixture of syn‐ and anti‐ isomers. Reduction of this mixture with LiAlH 4 proceeded by loss of ROH or RNH 2 to give racemic 3 ( Scheme 5 ).
18
Oral physostigmine and lecithin improve memory in Alzheimer disease
L. J. Thal, Paula Altman Fuld, David Masur et al. · Annals of Neurology · 1983 · 288 citations
Atsuyuki Ashimori, Benoit Bachand, Michael A. Calter et al. · Journal of the American Chemical Society · 1998 · 185 citations
A new and convenient method for converting olefins to aldehydes
James J. Pappas, William P. Keaveney, Edward Gancher et al. · Tetrahedron Letters · 1966 · 182 citations